
OncoDaily
@oncodaily
Your daily dose of hope, inspiration, and information in the fight against cancer.
ID: 1658531735448035333
https://oncodaily.com 16-05-2023 17:56:17
49,49K Tweet
6,6K Takipçi
7,7K Takip Edilen

Dipesh Uprety Highlighted Phase 3 IMforte trial on First-line Maintenance Therapy With Lurbinectedin Plus Atezolizumab in SCLC Dipesh Uprety MD FACP oncodaily.com/insight/lurbin… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews #Lurbinectedin #Atezolizumab #SCLC
